- Session I: Current Approaches to the Management of Heart Failure
- Session II: Electrophysiological Approaches to Heart Failure
- Session III: Latest on Surgical and Device Strategies for Advanced Heart Failure
- Session IV: Future Directions in Heart Failure Therapy: Biomarkers, Cardiomyopathy and Late Breaking Trials Future
- Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Thursday, July 17
11:00 – 1:20 pm
Registration, Check-In & Exhibits
11:55 – 1:00 pm
Buffet Lunch
12:00 – 1:00 pm
Industry Supported Lecture: A Near-Complete TTR Stabilizer Intentionally Designed for Patients with ATTR-CM
Allen Sawyer Anderson, MD, FACC, FAHA, FHFSA – Presented by BridgeBio
*Not eligible for CME credit
1:20 – 1:25 pm
Introduction and Program Overview
Kirkwood F. Adams, Jr., MD
Session I: Current Approaches to the Management of Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD
1:25 – 2:00 pm
Semaglutide for HFpEF
Javed Butler, MD, MPH, MBA
2:00 – 2:30 pm
ARNI and SGLT2i Therapy for HFpEF
Robert J. Mentz, MD and Javed Butler, MD, MPH, MBA
2:30 – 2:55 pm
Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF
Marvin A. Konstam, MD
2:55 – 3:30 pm
Optimizing Polypharmacy in HFpEF: Clinical Phenotypes and Pathophysiology
Moderator: Robert J. Mentz, MD
Panelists: Javed Butler, MD, MPH, MBA, Marvin A. Konstam, MD, Peter Carson, MD, and Kirkwood F. Adams, Jr., MD
3:30 – 3:45 pm
Break & Exhibits
3:45 – 4:10 pm
Recognition of Pre-Heart Failure: Role of Biomarkers and Omics – Treatment Implications
David E. Lanfear, MD and Kirkwood F. Adams, Jr., MD
4:10 – 4:50 pm
Optimizing Polypharmacy – Closing “Old School – New School” GDMT Treatment Gaps
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Stephanie H. Dunlap, DO, Stephen Greene, MD and Nancy M. Albert, PhD, RN
Panelists: Marvin Konstam, MD, Javed Butler, MD, MPH, MBA, and Alan B. Miller, MD
4:50 – 5:30 pm
Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion
Case Presenters: Stephanie H. Dunlap, DO
Case Discussants: Nancy M. Albert, PhD, RN, Stephanie H. Dunlap, DO, Robert L. Page II, PharmD, and Douglas D. Schocken, MD
Friday, July 18
7:00 – 8:00 am
Breakfast, Check-In & Exhibits
Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD
8:00 – 8:25 am
Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?
Anil K. Gehi, MD
8:25 – 8:40 am
EP Panel Discussion
Discussants: Alan B. Miller, MD and Anil K. Gehi, MD
Session III: Latest on Surgical and Device Strategies for Advanced Heart Failure
Moderator: Patricia P. Chang, MD, MHS
8:40 – 9:00 am
Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application
William Mostertz, MD
9:00 – 9:20 am
Real World Insights on Cardiac Assist Devices and Transplantation
James B. Young, MD
9:20 – 9:35 am
Break & Exhibits
9:35 – 9:55 am
Mitral and Tricuspid Valve Disease: Latest Treatment with Classic and Novel Interventions
William T. Abraham, MD
9:55 – 10:40 am
Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing
Moderators: Patricia P. Chang, MD, MHS and William Mostertz, MD
Case Presenter: Mason Sanders, MD
Panelists: James B. Young, MD
10:40 – 11:30 am
Featured Panel Discussion: Advanced Heart Failure: Application of Mechanical Circulatory Support and Left Ventricular Assist Devices
Moderator: Patricia P. Chang, MD, MHS
Speakers: Mustafa M. Ahmed, MD
Commentary: David Ishizawar, MD and David E. Lanfear, MD
Hot Topic – Update on Novel and Investigational Devices for Heart Failure
11:30 – 12:20 pm
Expert Panel Discussion: Novel and Investigational Devices for Monitoring and Treatment
Moderator: Alan B. Miller, MD
Speakers: Marvin A. Konstam, MD, Akshay Desai, MD, MPH, and Marat Fudim, MD, MHS
12:20 – 12:30 pm
Lunch Pick-Up & Exhibits
SATELLITE LUNCHEON SESSION
12:30 – 1:30 pm
Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk
Chair: Akshay Desai, MD, MPH
Faculty: Nancy Albert, PhD, Stephen Greene, MD, and Robert L. Page II, PharmD
This activity is hosted and accredited by Voxmedia.
Concurrent Workshops
1:30 – 2:30 pm
Nursing Challenges in Caring for the Chronic Heart Failure Patient
Sarah Waters, ANP-BC, Tonya Carter, DNP, NP-C, and Tammy Long, AGNP
Optimizing Patient Selection for EP Device and Intervention Therapy
Anil K. Gehi, MD and Faisal F. Syed, BSc, MBChB
Clinical Application of Biomarkers and Omics in Day to Day Heart Failure Patient Care
Kirkwood F. Adams, Jr., MD, Ileana L. Piña, MD, MPH, and David E. Lanfear, MD
Case-Based Interactive Discussion: How to Do an Effective Heart Failure History and Physical
Douglas D. Schocken, MD and Stephanie H. Dunlap, DO
Cardio-Oncology: Clinical Case Discussions
Jo Ellen Rodgers, PharmD, Susan Gilchrist, MD, MS, Sean O’Connor, PharmD, and Megan Earnhart, PharmD
Saturday, July 19
7:15 – 8:30 am
Breakfast, Check-In & Exhibits
Session IV: Future Directions in Heart Failure Therapy: Biomarkers, Cardiomyopathies, Congestion, and Obesity
Moderator: Kirkwood F. Adams, Jr., MD
9:00 – 9:25 am
Cardiac Amyloidosis: Beyond ATTR-CM
Mathew S. Maurer, MD
9:25 – 9:35 am
Clinical Discussion of Nuances in the Management of Cardiac Amyloid
Mathew S. Maurer, MD and Alan B. Miller, MD
9:35 – 10:05 am
Myosin Modulation: Update on Latest Drugs for Hypertrophic Cardiomyopathy
Anjali Owens, MD
10:05 – 10:15 am
Clinical Considerations to Optimize the Management of Hypertrophic Cardiomyopathy
Anjali Owens, MD and Kirkwood F. Adams, Jr., MD
10:15 – 10:30 am
Break & Exhibits
10:30 – 10:55 am
Recent Advances in Management of Congestion in CHF
Update on Loop Diuretic Application in CHF
Marvin A. Konstam, MD
Advances in Non-Loop Diuretic Rx of CHF
Kirkwood F. Adams, Jr., MD
10:55 – 11:20 am
Cardiovascular Effects of Obesity with Emphasis on Heart Failure – Rx Implication
Javed Butler, MD, MPH, MBA
11:20 – 12:20 pm
Expert Panel Discussion: Potential Opportunities and Challenges for Novel Therapies as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Christopher M. O’Connor, MD, Clyde W. Yancy, Jr., MD, MSc, and Larry Allen, MD
Panelists: Javed Butler, MD, MPH, MBA, Mona Fiuzat, PharmD, Barry Greenberg, MD, Stephen Greene, MD, and Ileana L. Piña, MD, MPH
12:20 – 12:30 pm
Lunch Pick-Up & Exhibits
SATELLITE LUNCHEON SESSION
12:30 – 1:30 pm
Clinical Clues, Diagnostic Pearls, and a Changing Therapeutic Landscape: Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
Chair: Mathew Maurer, MD Faculty: Sarah Cuddy, MD and Melissa Lyle, MD
*This activity is hosted and accredited by Voxmedia.
Concurrent Workshops
1:30 – 2:30 pm
Pharmacotherapeutic Challenges in Treating the Heart Failure Patient
Robert L. Page II, PharmD, Erika Schoenborn, PharmD, and Barry E. Bleske, PharmD
Treating Advanced and Refractory HF: Optimizing Pre-Op and Post-OP LVAD Care
Lauren B. Cooper, MD, Stephanie H. Dunlap, DO, and Megan Andrews, ANP
Unusual Cardiomyopathies: Approaches to Evaluation and Management
Mathew S. Maurer, MD, Anjali Owens, MD, Uri Elkayam, MD, and Sharon S. Natanzon, MD
Optimizing Device Therapy for HFrEF
William Mostertz, MD, Faisal F. Syed, BSc, MBChB, and Marat Fudim, MD, MHS
Pulmonary Arterial Hypertension: Latest Clinical Applications of Current Therapies
Lisa Rose-Jones, MD
Sunday, July 20
7:30 – 8:00 am
Continental Breakfast, Check-In & Exhibits
Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD
8:00 – 8:30 am
Optimizing Care in Heart Failure – Process Matters
Ileana L. Piña, MD, MPH
8:30 – 9:20 am
Care Team Roles in Management of Heart Failure Care
Moderator: Ileana L. Piña, MD, MPH
Panel Discussion: Tammy Long, AGNP, Erika Schoenborn, PharmD, Katherine Di Palo, PharmD, Sarah Waters, ANP-BC, Tonya Carter, DNP, NP-C, and Brenda Murphy, ARNP
9:20 – 10:05 am
Team Approach to Optimizing GDMT and Device Therapies
Tammy Long, AGNP, Erika Schoenborn, PharmD, Katherine Di Palo, PharmD, Sarah Waters, ANP-BC, Tonya Carter, DNP, NP-C, and Brenda Murphy, ARNP
10:05 – 10:30 am
Advancing the Cardiovascular Care of the Oncology Patient
Jo Ellen Rodgers, PharmD and Susan Gilchrist, MD, MS
10:30 – 10:55 am
Atrial Fibrillation: Consequences and Therapeutic Implications in CHF
Anil K. Gehi, MD
10:55 – 11:15 am
Optimizing Therapy in HF Patients with Sleep Disordered Breathing
William G. Cotts, MD
11:15 – 11:40 am
Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment
Lisa J. Rose-Jones, MD
11:40 – 12:00 pm
Current Clinical Approaches to Important Co-morbidities in Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD
Panel Discussion: Lisa J. Rose-Jones, MD, Jo Ellen Rodgers, PharmD, Susan Gilchrist, MD, MS, Anil K. Gehi, MD, and William G. Cotts, MD
12:00 pm
ADJOURN